Chris Martin is the founder of ADC Therapeutics. ADC Therapeutics has raised $65M in total funding. Latest round: Series A.
Chris Martin, DPhil, is the former CEO of ADC Therapeutics. He currently serves as the Board Chair for Tagworks Pharmaceuticals, a company specializing in Click-to-Release chemistry for systemic therapies. Tagworks recently secured $65 million in Series A financing.
Full founder directory · Investor directory · Company funding database · Fundraising library